Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 2 , Pages 135-147 , June 2005

Photodynamic therapy in the management of malignant pleural mesothelioma: A review

References 

  1. Wagner JC. Diffuse pleural mesothelioma and asbestos exposure in the North West Cape province. Br J Intern Med. 1960;17:260–271
  2. McDonald AD, McDonald JC. Asbestos related malignancy. In:  Antman K,  Aisner J editor. Epidemiology of malignant mesothelioma. Orlando: Grune and Stratton; 1987;p. 31–55
  3. Peto J, Hodgson JT, Mathews FF, Jones JR. Continuing increase in mesothelioma mortality in Britain. Lancet. 1995;345:5635–5639
  4. Muller KM. In: Remele W, editor. Pathologie, 2nd ed. Berlin; Springer; 1997. pp. 715–32.
  5. Muller KM. Pleural disease. In: Loddenkemper R, Antony VB, editors. European respiratory monograph 22. Eur Resp J 2002;7:12–25.
  6. Boutin CF, Schlesser M, Frenay C, Astoul PL. Malignant pleural mesothelioma. Eur Resp J. 1998;12:972–981
  7. Rusch V, Ginsberg R. New concept in the staging of mesothelioma. In:  Deslauriers J,  Lacquet LK editor. International trends in general thoracic surgery: surgical management of pleural disease. St Louis: The CV Mosby Company; 1990;p. 336–345
  8. International Mesothelioma Interest Group. A proposed new international TNM staging system for malignant pleural mesothelioma. Chest 1995;108:1122–8.
  9. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura. Review of 123 patients. Cancer. 1982;49:2431–2435
  10. Antman KH, Shemin R, Ryan L. Malignant mesothelioma: prognostic variables in a registry of 180 patients. The Dana-Fabre Cancer Institute and Brigham and Women's Hospital experience over two decades 1965–1985. J Clin Oncol. 1988;6:147–153
  11. Chahinian APH, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma (prospective evaluation of 69 patients). Ann Intern Med. 1982;96:746–755
  12. Huncharek M, Kelsy K, Mark EJ, et al. Treatment and survival in diffuse malignant pleural mesothelioma: a study of 83 cases from the Massachusetts General Hospital. Anticancer Res. 1996;16:1265–1268
  13. Harvey JC, Erdman C, Pisch J, Beattie EJ. Diffuse malignant mesothelioma. Options in surgical treatment. Comp Ther. 1995;21:13–19
  14. Chahinian AP, Pajack TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma, prospective evaluation of 69 patients. Ann Intern Med. 1982;96:746–755
  15. Law MR, Hodson MR, Turner-Warwick M. Malignant mesothelioma of the pleura, clinical aspects and symptomatic treatment. Eur J Resp Dis. 1984;64:162–166
  16. Sternman DH, Kaiser LR, Albelda SM. Advances in the treatment of malignant pleural mesothelioma. Chest. 1999;116:504–520
  17. Keller SM. Adjuvant therapy for malignant pleural mesothelioma (review). Chest Clin North Am. 1995;4:127–135
  18. Sugarbaker DJ, Jaklitsch AT, Liptay MJ. Mesothelioma and radical multi modality therapy: who benefits?. Chest. 1995;107(Suppl.):3455–3505
  19. Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuro pneumonectomy in the management of diffuse malignant mesothelioma of the pleura, experience with 29 patients. Thorax. 1976;31:15–24
  20. Perobst G, Buelzebruck H, Bauer HG, Branscheid D, Vogt-Moykoff I. The role of pleuropneumonectomy in diffuse malignant mesothelioma of the pleura. In:  Deslauries J,  Lacquet LK editor. International trends in general thoracic surgery: surgical management of pleural disease. Vol. 6:St Louis: The CV Mosby Company; 1990;p. 344–350
  21. Rusch VW, Piantadosi S, Holmes SC. The role of extra pleural pneumonectomy in malignant pleural mesothelioma: a Lung Cancer Study Group. Trial J Thorac Cardiovasc Surg. 1991;102:1–4
  22. Faber LP. Extra pleural pleuro-pneumonectomy for diffuse malignant mesothelioma. Ann Thorac Surg. 1995;58:1782–1783
  23. Pass HI, Pogrebniak HW. Malignant pleural mesothelioma. Curr Probl Surg. 1993;30:921–1012
  24. Aisner J. Current approach to malignant mesothelioma of the pleura. Chest. 1995;107:332S–344S
  25. Sugarbaker D, Garcia JP, Richards WG, et al. Extra pleural pneumonectomy in the multi modality therapy for malignant pleural mesothelioma results of 120 consecutive patients. Ann Thorac Surg. 1996;224:288–294
  26. Dougherty T, Kaufman JE, Goldfarb A, et al. A Photoradiation for the treatment of malignant tumour. Cancer Res. 1978;38:2628–2635
  27. Takita H, Mang TS, Loewen GM, et al. Operation and intracavitary photodynamic therapy for malignant pleural mesothelioma: a phase II study. Ann Thorac Surg. 1994;58:995–998
  28. Pass HI, DeLaney TF, Tochner Z, et al. Intrapleural photodynamic therapy: results of a phase I trial. Ann Surg Oncol. 1994;1:28–37
  29. Takita H, Dougherty TJ. Intracavitary photodynamic therapy for malignant pleural mesothelioma. Semin Surg Oncol. 1995;11:368–371
  30. Ris HB, Altermatt HJ, Nachbur B, et al. Intra-operative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies. Lasers Surg Med. 1996;18:39–45
  31. Baas P, Murrer L, Zoetmulder FA. Photodynamic therapy as adjuvant therapy in surgically treated pleural malignancies. Br J Cancer. 1997;76:819–826
  32. Pass HI, Temeck BK, Kranda K, et al. Phase III randomised trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 1997;4:628–633
  33. Moskal TL, Dougherty TJ, Urschel JD, et al. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow up. Ann Thorac Surg. 1998;66:1128–1133
  34. Schouwink H, Rutgers ET, van der Sijp J, et al. Intraoperative photodynamic therapy after pleuropneumonectomy in patients with malignant pleural mesothelioma: dose finding and toxicity results. Chest. 2001;120:1167–1174
  35. Friedberg JS, Mick R, Stevenson J, et al. A phase I study of Foscan™-mediated photodynamic therapy and surgery in patients with mesothelioma. Ann Thorac Surg. 2003;75:952–959
  36. Matzi V, Maier A, Sanki O, et al. Photodynamic Therapy enhanced by hyperbaric oxygenation in palliation of malignant pleural mesothelioma: clinical experience. Photodiagn Photodyn Ther. 2004;1:57–64
  37. Pass HI, Temeck BK, Kranda K, Steinberg SM, Feuerstein IR. Preoperative tumour volume is associated with outcome in malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 1998;115:310–317
  38. Rusch V, Saltz L, Venkatraman E, et al. A Phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol. 1994;12:1156–1163
  39. Soysal O, Karaoglanoglu N, Demiracan S, et al. Pleurectomy/decortication for palliation in malignant pleural mesothelioma, results of surgery. Eur J Cardiothorac Surg. 1997;11:210–213
  40. Aziz T, Jilaihawi A, Prakash D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg. 2002;22:298–305
  41. Sugarbaker DJ, Jaklitsch MT, Bueno R, et al. Prevention, early detection and management of complications after 328 consecutive extrapleural pneumonectomies. J Thorac Cardiovasc Surg. 2004;128:138–146
  42. Stewart DJ, Martin-Ucar AE, Edwards JG, West K, Waller DA. Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operation. Eur J Cardiothorac Surg. 2005;27:373–378
  43. Potter WR, Mang TS, Dougherty TJ. The theory of photodynamic therapy dosimetry consequences of photodestruction of photo-sensitizer. Photochem Photobiol. 1987;46:97–101
  44. Moghissi K, Dixon K, Stringer M, Freeman T, Thorpe A, Brown S. The place of bronchoscopic photodynamic therapy in advanced unresectable lung cancer: experience of 100 cases. Eur J Cardiothorac Surg. 1999;15:1–6
  45. Moghissi K, Dixon K, Thorpe JAC , Stringer M, Moore PJ. The role of photodynamic therapy (PDT) in inoperable oesophageal cancer. Eur J Cardiothorac Surg. 2000;17:95–100

PII: S1572-1000(05)00059-1

doi: 10.1016/S1572-1000(05)00059-1

Photodiagnosis and Photodynamic Therapy
Volume 2, Issue 2 , Pages 135-147 , June 2005

Article Tools

* Image Usage & Resolution